Search Results - I. Romanov
- Showing 1 - 14 results of 14
-
1
PROFESSIONAL DIAGNOSTICS OF PERSONNEL AS A TOOL TO INCREASE THE ECONOMIC EFFICIENCY OF THE ENTERPRISE by I. Romanovа
Published 2017-02-01
Article -
2
ECOLOGICAL-FAUNISTICAL REVIEW OF FISH PARASITES FROM THE LAKE SOBACH’E (PUTORANA PLATEAU) by K. V. Polyaeva, V. I. Romanov
Published 2016-12-01
Article -
3
Is the Transfer of Russian Engineering Education to the American Liberal Arts System Relevant? by A. I. Rudskoy, A. I. Borovkov, P. I. Romanov
Published 2021-07-01
Article -
4
RUSSIAN EXPERIENCE IN ENGINEERING EDUCATION DEVELOPMENT by A. I. RUDSKOY, A. I. BOROVKOV, P. I. ROMANOV
Published 2018-02-01
Article -
5
-
6
Scientific and Professional Degrees in Russia: Developing Traditions into the Future by A. I. Rudskoy, A. I. Borovkov, P. I. Romanov, N. S. Grishina
Published 2022-12-01
Article -
7
SYSTEMIC CARDIOVASCULAR OUTCOMES OF SLEEP RELATED BREATHING DISORDERS by D. Yu. Kallistov, A. I. Romanov, N. I. Novichkova, E. A. Romanova
Published 2016-09-01
Article -
8
-
9
GENERAL PROFESSIONAL COMPETENCE OF A MODERN RUSSIAN ENGINEER by A. I. RUDSKOY, A. I. BOROVKOV, P. I. ROMANOV, O. V. KOLOSOVA
Published 2018-02-01
Article -
10
THE CANDIDATE ENGINEERING ACADEMIC DEGREE REQUIRED NOW by A. I. Rudskoy, A. I. Borovkov, P. I. Romanov, K. N. Kiseleva
Published 2017-10-01
Article -
11
Fundamental Bases of Success and Prestige of National Engineering Education by A. I. Rudskoy, S. V. Kabyshev, A. I. Borovkov, P. I. Romanov, N. S. Grishina
Published 2025-02-01
Article -
12
Development of a polyurea-based composition with an extended life span by S. I. Romanov, O. A. Botvinova, E. A. Timakov, L. A. Chizhova, Yu. T. Panov
Published 2021-05-01
Article -
13
Molecular-Genetic and Phenotypic Peculiarities of Plague Agent Strains Isolated in Vietnam by L. M. Kukleva, K. A. Nikiforov, Zh. V. Al’khova, N. I. Romanov, N. Yu. Nosov, A. V. Fadeeva, A. N. Malakhaeva, N. A. Sharapova, Z. L. Devdariani, Yu. A. Popov, G. A. Eroshenko
Published 2017-12-01
Article -
14
A randomized study to evaluate the safety and efficacy of two dosages of lenvatinib – 18 and 24 mg – in patients with radioiodrefract differentiated thyroid cancer by M. S. Brose, Yu. Panaseykin, B. Konda, C. de la Fouchardiere, B. G.M. Hughes, A. G. Gianoukakis, Y. J. Park, I. Romanov, M. K. Krzyzanowska, S. Leboulleux, T. A. Binder, C. Dutcus, R. Xie, M. H. Taylor
Published 2022-04-01
Article